Stéphane Rocchi is a Directeur de Recherche 1 at Inserm, where they focus on new therapeutic targets against melanoma. They have led Research Group 12 at INSERM U1065 since 2018 and serve as the President of the Scientific Council of Canceropôle Provence-Alpes-Côte d'Azur since 2023. As a co-founder of Biper Therapeutics, Stéphane contributes to innovative cancer therapies. They previously held various research positions at INSERM, including as a Charge de Recherche 1 and 2, and completed their Postdoctoral studies at the IGBMC de Strasbourg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices